Comparison of post-treatment recurrence between ranibizumab injection and laser photocoagulation for type 1 retinopathy of prematurity
Abstract Objective To compare post-treatment recurrence between ranibizumab injection and laser photocoagulation (LP) for type 1 retinopathy of prematurity (ROP), and explore the associated risk factors. Methods The clinical data of ROP infants treated with LP or ranibizumab in a NICU of China from...
Main Authors: | Jing-Ke Cao, Tao Han, Hong-Yi Tang, Sheng Zhang, Zong-Hua Wang, Zhi-Chun Feng, Qiu-Ping Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-04-01
|
Series: | BMC Ophthalmology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12886-023-02886-5 |
Similar Items
-
Comparison of intravitreal ranibizumab and diod laser photocoagulation treatment for retinopathy of prematurity; effects on axial lenght and refractive status
by: Yusuf Koçluk, et al.
Published: (2019-03-01) -
Transscleral Diode Laser Photocoagulation for Type 1 Prethreshold Retinopathy of Prematurity
by: Mohammad Mehdi Parvaresh, et al.
Published: (2013-01-01) -
Comparison of intravitreal injection of Ranibizumab versus Conbercept in the treatment of retinopathy of prematurity
by: Chen Juan, et al.
Published: (2024-05-01) -
Bedside Diode Laser Photocoagulation Under Remifentanil Analgesia for Retinopathy of Prematurity: Early Structural Outcomes
by: Mehmet Ali Şekeroğlu, et al.
Published: (2016-10-01) -
Intravitreal injection of ranibizumab (Lucentis) versus pan-retinal photocoagulation as a preoperative adjuvant before vitrectomy in management of proliferative diabetic retinopathy
by: Mohammed S Ahmed
Published: (2021-01-01)